Cover Page
Cover Page - shares | 3 Months Ended | |
Mar. 30, 2024 | Apr. 30, 2024 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Entity Interactive Data Current | Yes | |
Document Period End Date | Mar. 30, 2024 | |
Document Fiscal Year Focus | 2024 | |
Document Fiscal Period Focus | Q1 | |
Document Transition Report | false | |
Document Quarterly Report | true | |
Entity Registrant Name | INTEVAC, INC. | |
Entity Central Index Key | 0001001902 | |
Current Fiscal Year End Date | --12-30 | |
Entity Current Reporting Status | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Trading Symbol | IVAC | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity File Number | 0-26946 | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 94-3125814 | |
Entity Address, Address Line One | 3560 Bassett Street | |
Entity Address, City or Town | Santa Clara | |
Entity Address, State or Province | CA | |
Entity Address, Postal Zip Code | 95054 | |
City Area Code | 408 | |
Local Phone Number | 986-9888 | |
Entity Small Business | true | |
Title of 12(b) Security | Common Stock | |
Entity Common Stock, Shares Outstanding | 26,584,057 | |
Security Exchange Name | NASDAQ |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Mar. 30, 2024 | Dec. 30, 2023 |
Current assets: | ||
Cash and cash equivalents | $ 45,750 | $ 51,441 |
Short-term investments | 18,094 | 17,405 |
Trade and other accounts receivable, net of allowances of $0 at both March 30, 2024 and December 30, 2023 | 25,136 | 18,613 |
Inventories | 45,808 | 43,795 |
Prepaid expenses and other current assets | 2,387 | 2,123 |
Total current assets | 137,175 | 133,377 |
Operating lease right-of-use assets | 7,182 | 7,658 |
Long-term investments | 922 | 2,687 |
Restricted cash | 700 | 700 |
Property, plant and equipment, net | 7,149 | 7,664 |
Intangible assets, net of amortization of $212 at March 30, 2024 and $178 at December 30, 2023 | 920 | 954 |
Deferred income taxes and other long-term assets | 3,194 | 3,466 |
Total assets | 157,242 | 156,506 |
Current liabilities: | ||
Current operating lease liabilities | 902 | 1,008 |
Accounts payable | 5,494 | 5,800 |
Accrued payroll and related liabilities | 2,837 | 3,475 |
Other accrued liabilities | 1,955 | 1,820 |
Customer advances | 23,044 | 20,407 |
Total current liabilities | 34,232 | 32,510 |
Noncurrent liabilities: | ||
Noncurrent operating lease liabilities | 6,591 | 6,976 |
Customer advances | 1,482 | 1,482 |
Other long-term liabilities | 14 | 21 |
Total noncurrent liabilities | 8,087 | 8,479 |
Stockholders' equity: | ||
Common stock, $0.001 par value | 27 | 26 |
Additional paid-in capital | 211,398 | 210,320 |
Treasury stock, 5,087 shares at both March 30, 2024 and December 30, 2023 | (29,551) | (29,551) |
Accumulated other comprehensive income | 30 | 97 |
Accumulated deficit | (66,981) | (65,375) |
Total stockholders' equity | 114,923 | 115,517 |
Total liabilities and stockholders' equity | $ 157,242 | $ 156,506 |
CONDENSED CONSOLIDATED BALANC_2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands | Mar. 30, 2024 | Dec. 30, 2023 |
Statement of Financial Position [Abstract] | ||
Net of allowances of trade, note and other accounts receivable | $ 0 | $ 0 |
Net of amortization of intangible assets | $ 212 | $ 178 |
Common stock, par value | $ 0.001 | $ 0.001 |
Treasury stock, shares | 5,087 | 5,087 |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 30, 2024 | Apr. 01, 2023 | |
Net revenues: | ||
Total net revenues | $ 9,631 | $ 11,542 |
Cost of net revenues: | ||
Total cost of net revenues | 5,427 | 6,823 |
Gross profit | 4,204 | 4,719 |
Operating expenses: | ||
Research and development | 4,369 | 3,973 |
Selling, general and administrative | 4,281 | 5,200 |
Total operating expenses | 8,650 | 9,173 |
Loss from operations | (4,446) | (4,454) |
Interest income and other income (expense), net | 2,221 | 672 |
Loss from continuing operations before provision for income taxes | (2,225) | (3,782) |
Provision for income taxes | 476 | 386 |
Net loss from continuing operations | (2,701) | (4,168) |
Income (loss) from discontinued operations, net of tax | 1,095 | 277 |
Net loss | $ (1,606) | $ (3,891) |
Net income (loss) per share: | ||
Basic—continuing operations | $ (0.1) | $ (0.16) |
Diluted—continuing operations | (0.1) | (0.16) |
Basic—discontinued operations | 0.04 | 0.01 |
Diluted—discontinued operations | 0.04 | 0.01 |
Basic—net income (loss) | (0.06) | (0.15) |
Diluted—net income (loss) | $ (0.06) | $ (0.15) |
Weighted average shares outstanding: | ||
Basic | 26,522 | 25,781 |
Diluted | 26,522 | 25,781 |
CONDENSED CONSOLIDATED STATEM_2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 30, 2024 | Apr. 01, 2023 | |
Statement Of Income And Comprehensive Income [Abstract] | ||
Net loss | $ (1,606) | $ (3,891) |
Other comprehensive income (loss), before tax | ||
Change in unrealized net loss on available-for-sale investments | 29 | 169 |
Foreign currency translation losses | (96) | 10 |
Other comprehensive income (loss), before tax | (67) | 179 |
Income tax expense related to items in other comprehensive income (loss) | 0 | 0 |
Other comprehensive income (loss), net of tax | (67) | 179 |
Comprehensive loss | $ (1,673) | $ (3,712) |
CONDENSED CONSOLIDATED STATEM_3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 30, 2024 | Apr. 01, 2023 | |
Operating activities | ||
Net loss | $ (1,606) | $ (3,891) |
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities: | ||
Depreciation and amortization | 558 | 344 |
Net amortization (accretion) of investment premiums and discounts | (83) | (61) |
Amortization of intangible assets | 34 | 34 |
Equity-based compensation | 761 | 1,581 |
Straight-line rent adjustment and amortization of lease incentives | (15) | (249) |
(Gain) loss on disposal of fixed assets | 523 | (65) |
Deferred income taxes | 299 | 197 |
Changes in operating assets and liabilities | (7,006) | (21,491) |
Total adjustments | (4,929) | (19,710) |
Net cash used in operating activities | (6,535) | (23,601) |
Investing activities | ||
Purchase of investments | (7,099) | (1,989) |
Proceeds from sales and maturities of investments | 8,287 | 14,095 |
Proceeds from sales of property and equipment | 0 | 65 |
Purchase of leasehold improvements and equipment | (566) | (4,005) |
Net cash provided by investing activities | 622 | 8,166 |
Financing activities | ||
Proceeds from issuance of common stock | 462 | 835 |
Payment of acquisition-related contingent consideration | 0 | (250) |
Taxes paid related to net share settlement | (144) | (1,274) |
Net cash provided by (used in) financing activities | 318 | (689) |
Effect of exchange rate changes on cash and cash equivalents | (96) | 10 |
Net decrease in cash, cash equivalents and restricted cash | (5,691) | (16,114) |
Cash, cash equivalents and restricted cash at beginning of period | 52,141 | 69,690 |
Cash, cash equivalents and restricted cash at end of period | $ 46,450 | $ 53,576 |
Description of Business, Basis
Description of Business, Basis of Presentation and Significant Accounting Policy | 3 Months Ended |
Mar. 30, 2024 | |
Accounting Policies [Abstract] | |
Description of Business, Basis of Presentation and Significant Accounting Policy | 1. Description of Business, Basis of Presentation and Significant Accounting Policy Description of Business Intevac, Inc. (together with its subsidiaries, “Intevac”, the “Company” or “we”) is a leader in the design and development of high-productivity, thin-film processing systems. Intevac’s production-proven platforms are designed for high-volume manufacturing of substrates with precise thin-film properties, such as for the hard disk drive (“HDD”) and advanced coatings (“ADVC”) (formerly known as display cover panel (“DCP”)) markets. Principles of Consolidation and Basis of Presentation The condensed consolidated financial statements include the accounts of Intevac, Inc. and its subsidiaries after elimination of inter-company balances and transactions. In the opinion of management, the unaudited interim condensed consolidated financial statements of Intevac included herein have been prepared on a basis consistent with the December 30, 2023 audited consolidated financial statements and include all material adjustments, consisting of normal recurring adjustments, necessary to fairly present the information set forth therein. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. Reportable Segment During fiscal 2021, we sold the business of one of our reporting segments, Photonics. Therefore, we have one reportable segment remaining. See Note 2 for additional disclosure related to discontinued operations. The remaining segment, Thin Film Equipment (“TFE”), designs, develops and markets vacuum process equipment solutions for high-volume manufacturing of small substrates with precise thin-film properties, such as for the HDD and ADVC markets, as well as other adjacent thin-film markets. The TFE segment also previously designed, developed and marketed manufacturing equipment for the photovoltaic (“PV”) solar cell and advanced semiconductor packaging (“ASP”) industries. In March 2022, the Company’s management realigned its operational focus and eliminated several research and development (“R&D”) programs and product offerings. As part of this realignment effort, the Company ceased its efforts to develop and market several of its manufacturing platforms for the ADVC, PV and ASP industries. Government Grants and Credits Government assistance is recognized when there is reasonable assurance that the Company will comply with the conditions attached to the grant arrangement and the grant will be received. Reimbursements of eligible expenditures pursuant to government assistance programs are recorded when the related costs have been incurred and there is reasonable assurance regarding collection of the claim. Grant claims not settled by the balance sheet date are recorded as receivables, provided their receipt is reasonably assured. The determination of the amount of the claim, and accordingly the receivable amount, requires management to make calculations based on its interpretation of eligible expenditures in accordance with the terms of the programs. The reimbursement claims submitted by the Company are subject to review by the relevant government agencies. During the three months ended March 30, 2024, we amended certain fiscal year 2021 payroll tax filings and applied for a refund equal to $2.4 million of Employee Retention Credit (“ERC”) benefits from the U.S. government. The refund is recorded within trade and other accounts receivable in our condensed consolidated balance sheet as of March 30, 2024, and as $1.5 million in other income (expense), net and $933,000 in discontinued operations in our condensed consolidated statements of operations for the three months ended March 30, 2024. (See Note 12. Income Taxes.) |
Divestiture and Discontinued Op
Divestiture and Discontinued Operations | 3 Months Ended |
Mar. 30, 2024 | |
Disposal Group, Including Discontinued Operation, Balance Sheet Disclosures [Abstract] | |
Divestiture and Discontinued Operations | 2. Divestiture and Discontinued Operations Sale of Photonics On December 30, 2021, the Company entered into an asset purchase agreement (the “Purchase Agreement”) with EOTECH, LLC (“EOTECH”) governing the sale of the Company’s Photonics business to EOTECH in exchange for (i) $70.0 million in cash consideration, (ii) up to $30.0 million in earnout payments and (iii) the assumption by EOTECH of certain liabilities of the Photonics business as specified in the Purchase Agreement. The transaction closed on December 30, 2021. Under the Purchase Agreement, EOTECH has also agreed to pay to the Company, if earned, earnout payments of up to an aggregate of $30.0 million based on achievement of fiscal year 2023, 2024 and 2025 Photonics segment revenue targets for the Integrated Visual Augmentation System (“IVAS”) program as specified in the Purchase Agreement. As of March 30, 2024, there have been no earnout payments under the Purchase Agreement. At any time prior to December 31, 2024, EOTECH may elect to pay to the Company $14.0 million, which would terminate EOTECH’s obligations with respect to any remaining earnout payments. The cash proceeds do not include any estimated future payments from the revenue earnout as the Company has elected to record the proceeds when the consideration is deemed realizable. The Company believes the disposition of the Photonics business will allow it to benefit from a streamlined business model, simplified operating structure, and enhanced management focus. In connection with the Photonics sale, the Company and EOTECH also entered into a Transition Service Agreement (the “TSA”) and a Lease Assignment Agreement. The TSA, which expired on June 30, 2022, outlined the information technology, people, and facility support the parties provided to each other for a period after the closing of the sale. The Lease Assignment Agreement assigns the lease obligation for two buildings in the Company’s California campus to EOTECH. As part of the assignment, the Company agreed to subsidize a portion of EOTECH’s lease payments through the remainder of the lease term which expired in March 2024. In August 2022, Intevac and EOTECH entered into a Shared Services Agreement (the “Shared Services Agreement”) to share certain building maintenance costs. Fees earned under the Shared Services Agreement for the three months ended March 30, 2024 and April 1, 2023 were $37,000 and $25,000, respectively. As of March 30, 2024 and December 30, 2023, accounts receivable from EOTECH of $10,000 and $62,000, respectively, were included in trade and other accounts receivable in the Company’s condensed consolidated balance sheets. Based on its magnitude and because the Company exited certain markets, the sale of the Photonics segment represents a significant strategic shift that has a material effect on the Company’s operations and financial results, and the Company has separately reported the results of its Photonics segment as discontinued operations in the condensed consolidated statements of operations for the three months ended March 30, 2024 and April 1, 2023. The key components from discontinued operations related to the Photonics segment are as follows: Three Months Ended March 30, April 1, (In thousands) Operating expenses: Selling, general and administrative $ (162 ) $ (277 ) Total operating expenses (162 ) (277 ) Operating income – discontinued operations 162 277 Other income (expense) – discontinued operations 933 — Income from discontinued operations before provision for income taxes 1,095 277 Provision for income taxes — — Net income from discontinued operations, net of taxes $ 1,095 $ 277 The cash flows related to discontinued operations have not been segregated and are included in the condensed consolidated statements of cash flows. The following table presents cash flow and non-cash Three Months Ended March 30, April 1, 2023 (In thousands) Equity-based compensation $ — $ (260 ) |
Revenue
Revenue | 3 Months Ended |
Mar. 30, 2024 | |
Revenue from Contract with Customer [Abstract] | |
Revenue | 3. Revenue The following tables represent a disaggregation of revenue from contracts with customers for the three months ended March 30, 2024 and April 1, 2023. Major Products and Service Lines Three Months Ended Three Months Ended April 1, 2023 (In thousands) HDD HDD PV Total Systems, upgrades and spare parts $ 8,119 $ 10,517 $ 18 $ 10,535 Field service 1,512 1,007 — 1,007 Total net revenues $ 9,631 $ 11,524 $ 18 $ 11,542 Revenue by Geographic Region Three Months Ended March 30, April 1, 2023 (In thousands) United States $ 482 $ 1,614 Asia 9,149 9,928 Total net revenues $ 9,631 $ 11,542 Timing of Revenue Recognition Three Months Ended March 30, April 1, 2023 (In thousands) Products transferred at a point in time $ 9,631 $ 11,542 Products and services transferred over time — — Total net revenues $ 9,631 $ 11,542 The following table reflects the changes in our contract assets, which we classify as accounts receivable, unbilled, and our contract liabilities, which we classify as deferred revenue and customer advances, for the three months ended March 30 2024. March 30, December 30, Three Months Change (In thousands) Contract assets: Accounts receivable, unbilled $ 884 $ 393 $ 491 Contract liabilities: Deferred revenue $ 476 $ 376 $ 100 Customer advances 24,526 21,889 2,637 $ 25,002 $ 22,265 $ 2,737 Accounts receivable, unbilled represents a contract asset for revenue that has been recognized in advance of billing the customer. For our system and certain upgrade sales, our customers generally pay in three installments, with a portion of the system price billed upon receipt of an order, a portion of the price billed upon shipment, and the balance of the price due upon completion of installation and acceptance of the system at the customer’s factory. Accounts receivable, unbilled generally represents the balance of the system price that is due upon completion of installation and acceptance, less the amount that has been deferred as revenue for the performance of the installation tasks. During the three months ended March 30, 2024, contract assets increased by $491,000 primarily due to the accrual of revenue related to the sale of spare parts sold to a customer as of March 30, 2024. Customer advances generally represent a contract liability for amounts billed to the customer prior to transferring goods. The Company has elected to use the practical expedient to disregard the effect of the time value of money in a significant financing component when its payment terms are less than one year. These customer advances are liquidated when revenue is recognized. Deferred revenue generally represents a contract liability for amounts billed to a customer for completed systems at the customer site that are undergoing installation and acceptance testing where transfer of control has not yet occurred as Intevac does not yet have a demonstrated history of meeting the acceptance criteria upon the customer’s receipt of product. During the three months ended March 30, 2024, we recognized revenue of $66,000 that was included in deferred revenue at the beginning of the period. In May 2023, the Company received notice of the cancellation of a $54.6 million order for eight 200 Lean HDD systems due to the customer postponing previously planned media capacity additions, and, accordingly, the Company removed the order from backlog. The customer contract associated with the cancelled order requires the customer to pay the Company a prorated price based upon the percentage of work completed on the order. The Company has received customer advances in the amount of $19.1 million associated with the cancelled order, all of which will be utilized to settle this customer obligation. In September 2023, the Company applied $444,000 of billings against these advances in connection with inventory scrapped at the customer’s direction. In December 2023, the Company received notice of the cancellation of a $11.4 million order for two 200 Lean HDD systems due to the customer postponing previously planned media capacity additions, and, accordingly, the Company removed the order from backlog. The Company has not received any customer advances associated with the cancelled order. The Company expects to invoice the customer in the second quarter of fiscal 2024 for the cancellation fee associated with this order. On March 30, 2024, we had $53.1 million of remaining performance obligations, which we also refer to as total backlog. We expect to recognize approximately 55.4% of our remaining performance obligations as revenue in 2024 and 44.6% in 2025. |
Inventories
Inventories | 3 Months Ended |
Mar. 30, 2024 | |
Inventory Disclosure [Abstract] | |
Inventories | 4. Inventories Inventories are stated at the lower of average cost or net realizable value and consist of the following: March 30, 2024 December 30, 2023 (In thousands) Raw materials $ 35,755 $ 37,346 Work-in-progress 10,053 6,449 $ 45,808 $ 43,795 In May 2023, the Company received notice of the cancellation of a $54.6 million order for eight 200 Lean HDD systems. In December 2023, the Company received notice of the cancellation of a $11.4 million order for two 200 Lean HDD systems. The customer contract associated with the cancelled orders requires the customer to pay the Company a prorated price based upon the percentage of work completed on the order. The Company has received customer advances in the amount of $19.1 million associated with the cancelled order for eight 200 Lean HDD systems, all of which will be utilized to settle this customer obligation. The Company has not received any customer advances associated with the cancelled order for two 200 Lean HDD systems. The Company expects to invoice the customer in the second quarter of 2024 for the cancellation fee associated with this order. In fiscal 2024, as part of the cancellation of the orders for the ten 200 Lean HDD systems, the customer is expected to take delivery of $11.8 million of inventory on hand at March 30, 2024 and $4.0 million of inventory on order, plus reimburse us for any supplier cancellation charges and the costs associated with managing the inventory. A portion of the inventory will be utilized to satisfy other outstanding purchase orders from this customer in backlog. |
Equity-Based Compensation
Equity-Based Compensation | 3 Months Ended |
Mar. 30, 2024 | |
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] | |
Equity-Based Compensation | 5. Equity-Based Compensation At March 30, 2024, Intevac had equity-based awards outstanding under the 2020 Equity Incentive Plan, the 2012 Equity Incentive Plan, the 2022 Inducement Equity Incentive Plan (the “Inducement Plan”) (together, the “Plans”) and the 2003 Employee Stock Purchase Plan (the “ESPP”). Intevac’s stockholders approved the 2020 Equity Incentive Plan, the 2012 Equity Incentive Plan and the ESPP. The Plans permit the grant of incentive or non-statutory On January 19, 2022, Intevac’s Board of Directors adopted the Inducement Plan and, subject to the adjustment provisions of the Inducement Plan, reserved 1,200,000 shares of the Company’s common stock for issuance pursuant to equity awards granted under the Inducement Plan. The Inducement Plan provides for the grant of equity-based awards, including nonstatutory stock options, restricted stock units, restricted stock, stock appreciation rights, performance shares and performance units, and its terms are substantially similar to the Company’s 2020 Equity Incentive Plan. The Inducement Plan was adopted without stockholder approval pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules. In accordance with that rule, awards under the Inducement Plan may only be made to individuals not previously employees or non-employee non-employment The ESPP provides that eligible employees may purchase Intevac’s common stock through payroll deductions at a price equal to 85% of the lower of the fair market value at the entry date of the applicable offering period or at the end of each applicable purchase interval. Offering periods are generally two years in length and consist of a series of six-month six-month Compensation Expense The effect of recording equity-based compensation for the three months ended March 30, 2024 and April 1, 2023 was as follows: Three Months Ended March 30, April 1, (In thousands) Equity-based compensation by type of award: Stock options $ — $ (13 ) RSUs 533 599 PRSUs 91 798 ESPP purchase rights 137 197 Total equity-based compensation $ 761 $ 1,581 Included in the table above are: (a) Equity-based compensation reported in discontinued operations of ($ 260,000 Stock Options and ESPP The fair value of stock options and ESPP awards is estimated at the grant date using the Black-Scholes option valuation model. The determination of the fair value of stock options and ESPP awards on the date of grant using an option-pricing model is affected by Intevac’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, our expected stock price volatility over the term of the awards, and actual employee stock option exercise behavior. Intevac accounts for forfeitures as they occur, rather than by estimating expected forfeitures. Option activity as of March 30, 2024 and changes during the three months ended March 30, 2024 were as follows: Shares Weighted-Average Options outstanding at December 30, 2023 142,000 $ 6.57 Options cancelled and forfeited (9,000 ) $ 7.71 Options outstanding at March 30, 2024 133,000 $ 6.50 Options exercisable at March 30, 2024 133,000 $ 6.50 Intevac issued 153,595 shares of common stock under the ESPP during the three months ended March 30, 2024. Intevac estimated the weighted-average fair value of ESPP purchase rights using the following weighted-average assumptions: Three Months Ended March 30, April 1, ESPP Purchase Rights: Weighted-average fair value of grants per share $ 1.41 $ 2.23 Expected volatility 47.81 % 34.20 % Risk-free interest rate 4.52 % 4.47 % Expected term of purchase rights (in years) 1.0 1.0 Dividend yield None None The computation of the expected volatility assumptions used in the Black-Scholes calculations for ESPP purchase rights is based on the historical volatility of Intevac’s stock price, measured over a period equal to the expected term of the purchase right. The risk-free interest rate is based on the yield available on U.S. Treasury Strips with an equivalent remaining term. The expected term of purchase rights represents the period of time remaining in the current offering period. The dividend yield assumption is based on Intevac’s history of not paying dividends and the assumption of not paying dividends in the future. RSUs A summary of the RSU activity is as follows: Shares Weighted-Average Grant Date Fair Value Non-vested 915,087 $ 4.89 Granted 51,925 $ 3.97 Vested (67,263 ) $ 5.39 Cancelled and forfeited (8,654 ) $ 5.62 Non-vested 891,095 $ 4.79 Time-based RSUs are converted into shares of Intevac common stock upon vesting on a one-for-one A summary of the PRSU activity is as follows: Shares Weighted-Average Grant Date Fair Value Non-vested 1,160,293 $ 4.04 Vested — $ — Cancelled and forfeited — $ — Non-vested 1,160,293 $ 4.04 We granted PRSUs in fiscal 2022 and fiscal 2023. These awards may vest based on our performance against one or more specified metrics, including achievement of certain stock prices during a three-year performance period in the case of the PRSUs granted in fiscal 2022 and achievement of strategic goals during a three-year performance period in the case of the PRSUs granted in fiscal 2023. |
Warranty
Warranty | 3 Months Ended |
Mar. 30, 2024 | |
Guarantees [Abstract] | |
Warranty | 6. Warranty Intevac provides for the estimated cost of warranty when revenue is recognized. Intevac’s warranty is subject to contract terms and, for its systems, the warranty typically ranges between 12 and 24 months from customer acceptance. During this warranty period any defective non-consumable On the condensed consolidated balance sheets, the short-term portion of the warranty provision is included in other accrued liabilities, while the long-term portion, if any, is included in other long-term liabilities. The expense associated with product warranties issued or adjusted is included in cost of net revenues on the condensed consolidated statements of operations. The following table displays the activity in the warranty provision account for the three months ended March 30, 2024 and April 1, 2023. Three Months Ended March 30, 2024 April 1, 2023 (In thousands) Opening balance $ 205 $ 163 Expenditures incurred under warranties (36 ) (97 ) Accruals for product warranties issued during the reporting period 38 100 Adjustments to previously existing warranty accruals (48 ) 11 Closing balance $ 159 $ 177 The following table displays the balance sheet classification of the warranty provision account at March 30, 2024 and at December 30, 2023. March 30, December 30, (In thousands) Other accrued liabilities $ 145 $ 184 Other long-term liabilities 14 21 Total warranty provision $ 159 $ 205 |
Guarantees
Guarantees | 3 Months Ended |
Mar. 30, 2024 | |
Guarantees [Abstract] | |
Guarantees | 7. Guarantees Officer and Director Indemnifications As permitted or required under Delaware law and to the maximum extent allowable under that law, Intevac has certain obligations to indemnify its current and former officers and directors for certain events or occurrences while the officer or director is, or was, serving at Intevac’s request in such capacity. These indemnification obligations are valid as long as the director or officer acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the Company and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. The maximum potential amount of future payments Intevac could be required to make under these indemnification obligations is unlimited; however, Intevac has a director and officer insurance policy that mitigates Intevac’s exposure and enables Intevac to recover a portion of any future amounts paid. As a result of Intevac’s insurance policy coverage, Intevac believes the estimated fair value of these indemnification obligations is not material. Other Indemnifications As is customary in Intevac’s industry, many of Intevac’s contracts provide remedies to certain third parties such as defense, settlement, or payment of judgments for intellectual property claims related to the use of its products. Such indemnification obligations may not be subject to maximum loss clauses. Historically, payments made related to these indemnifications have been immaterial. Letters of Credit As of March 30, 2024, we had letters of credit and bank guarantees outstanding totaling $700,000, including the standby letter of credit outstanding under the Santa Clara, California facility lease and various other guarantees with our bank. These letters of credit and bank guarantees are collateralized by $700,000 of restricted cash. |
Cash, Cash Equivalents and Inve
Cash, Cash Equivalents and Investments | 3 Months Ended |
Mar. 30, 2024 | |
Investments All Other Investments [Abstract] | |
Cash, Cash Equivalents and Investments | 8. Cash, Cash Equivalents and Investments Cash and cash equivalents, short-term investments and long-term investments consist of: March 30, 2024 Amortized Cost Unrealized Unrealized Fair Value (In thousands) Cash and cash equivalents: Cash $ 15,100 $ — $ — $ 15,100 Money market funds 15,183 — — 15,183 Commercial paper 14,474 — 6 14,468 U.S. treasury securities 999 — — 999 Total cash and cash equivalents $ 45,756 $ — $ 6 $ 45,750 Short-term investments: Certificates of deposit $ 300 $ — $ — $ 300 Commercial paper 6,610 — 3 6,607 Corporate bonds and medium-term notes 5,491 — 18 5,473 Municipal bonds 221 — 2 219 U.S. treasury and agency securities 5,500 — 5 5,495 Total short-term investments $ 18,122 $ — $ 28 $ 18,094 Long-term investments: Asset backed securities $ 206 $ — $ 2 $ 204 Corporate bonds and medium-term notes 715 3 — 718 Total long-term investments $ 921 $ 3 $ 2 $ 922 Total cash, cash equivalents, and investments $ 64,799 $ 3 $ 36 $ 64,766 December 30, 2023 Amortized Cost Unrealized Unrealized Fair Value (In thousands) Cash and cash equivalents: Cash $ 19,050 $ — $ — $ 19,050 Money market funds 15,090 — — 15,090 Commercial paper 14,659 — 4 14,655 U.S. treasury securities 2,646 — — 2,646 Total cash and cash equivalents $ 51,445 $ — $ 4 $ 51,441 Short-term investments: Asset backed securities $ 12 $ — $ — $ 12 Certificates of deposit 1,850 — — 1,850 Commercial paper 3,506 — 1 3,505 Corporate bonds and medium-term notes 5,373 — 36 5,337 Municipal bonds 221 — 2 219 U.S. treasury and agency securities 6,498 1 17 6,482 Total short-term investments $ 17,460 $ 1 $ 56 $ 17,405 Long-term investments: Asset backed securities $ 460 $ — $ 4 $ 456 Corporate bonds and medium-term notes 2,230 1 — 2,231 Total long-term investments $ 2,690 $ 1 $ 4 $ 2,687 Total cash, cash equivalents, and investments $ 71,595 $ 2 $ 64 $ 71,533 The contractual maturities of investment securities at March 30, 2024 are presented in the following table. Amortized Cost Fair Value (In thousands) Due in one year or less $ 48,778 $ 48,744 Due after one through five years 921 922 $ 49,699 $ 49,666 We periodically review investments for impairment. For investments in unrealized loss positions, we assess whether any portion of the decline in fair value below the amortized cost basis is due to credit-related factors if the Company neither intends to sell nor anticipates that it is more likely than not that we will be required to sell prior to recovery of the amortized cost basis. We consider factors such as the extent to which the market value has been less than the amortized cost basis, any noted failure of the issuer to make scheduled interest or principal payments, changes to the rating of the security by a rating agency and other relevant credit-related factors in determining whether or not a credit loss exists. We reassess our estimated credit losses on investments each reporting period. U.S. government securities and cash equivalents are under a “zero-loss available-for-sale Our investment portfolio includes both corporate and U.S. government securities that have a maximum maturity of two years. The longer the duration of these securities, the more susceptible they are to changes in market interest rates and bond yields. As yields increase, those securities with a lower yield-at-cost mark-to-market changes in market interest rates and bond yields. We believe that we have the ability to realize the full value of all these investments upon maturity. As of March 30, 2024, we had 77 investments in a gross unrealized loss position. The following table provides the fair market value of Intevac’s investments with unrealized losses that are not deemed to be other-than temporarily impaired as of March 30, 2024. March 30, 2024 In Loss Position for Less than 12 Months In Loss Position for Greater than 12 Months Fair Value Gross Unrealized Fair Value Gross Unrealized (In thousands) Asset backed securities $ — $ — $ 204 $ 2 Commercial paper 21,075 9 — — Corporate bonds and medium-term notes 2,007 5 3,466 13 Municipal bonds — — 219 2 U.S. treasury securities — — 1,995 5 $ 23,082 $ 14 $ 5,884 $ 22 All prices for the fixed maturity securities including U.S. treasury and agency securities, certificates of deposit, commercial paper, corporate bonds, asset backed securities and municipal bonds are received from independent pricing services utilized by Intevac’s outside investment manager. This investment manager performs a review of the pricing methodologies and inputs utilized by the independent pricing services for each asset type priced by the vendor. In addition, on at least an annual basis, the investment manager conducts due diligence visits and interviews with each pricing vendor to verify the inputs utilized for each asset class. The due diligence visits include a review of the procedures performed by each vendor to ensure that pricing evaluations are representative of the price that would be received if a security were sold in an orderly transaction. Any pricing where the input is based solely on a broker price is deemed to be a Level 3 price. Intevac uses the pricing data obtained from its outside investment manager as the primary input to make its assessments and determinations as to the ultimate valuation of the above-mentioned securities and has not made, during the periods presented, any material adjustments to such inputs. The following table represents the fair value hierarchy of Intevac’s investment securities measured at fair value on a recurring basis as of March 30, 2024. Fair Value Measurements at March 30, 2024 Total Level 1 Level 2 (In thousands) Recurring fair value measurements: Investment securities Money market funds $ 15,183 $ 15,183 $ — U.S. treasury and agency securities 6,494 2,994 3,500 Asset backed securities 204 — 204 Certificates of deposit 300 — 300 Commercial paper 21,075 — 21,075 Corporate bonds and medium-term notes 6,191 — 6,191 Municipal bonds 219 — 219 Total recurring fair value measurements $ 49,666 $ 18,177 $ 31,489 |
Derivative Instruments
Derivative Instruments | 3 Months Ended |
Mar. 30, 2024 | |
Derivative Instrument Detail [Abstract] | |
Derivative Instruments | 9. Derivative Instruments The Company uses foreign currency forward contracts to mitigate variability in gains and losses generated from the re-measurement re-measurement There were no outstanding derivatives at March 30, 2024 and December 30, 2023. |
Equity
Equity | 3 Months Ended |
Mar. 30, 2024 | |
Equity [Abstract] | |
Equity | 10. Equity Condensed Consolidated Statements of Changes in Equity The changes in stockholders’ equity by component for the three months ended March 30, 2024 and April 1, 2023, are as follows (in thousands): Three Months Ended March 30, 2024 Common Paid-in Treasury Accumulated Accumulated Total Balance at December 30, 2023 $ 210,346 $ (29,551 ) $ 97 $ (65,375 ) $ 115,517 Common stock issued under employee plans 462 — — — 462 Shares withheld for net share settlement of RSUs (144 ) — — — (144 ) Equity-based compensation expense 761 — — — 761 Net loss — — — (1,606 ) (1,606 ) Other comprehensive loss — — (67 ) — (67 ) Balance at March 30, 2024 $ 211,425 $ (29,551 ) $ 30 $ (66,981 ) $ 114,923 Three Months Ended April 1, 2023 Common Paid-in Treasury Accumulated Accumulated Total Balance at December 31, 2022 $ 206,381 $ (29,551 ) $ (193 ) $ (53,185 ) $ 123,452 Common stock issued under employee plans 801 — — — 801 Shares withheld for net share settlement of RSUs (1,274 ) — — — (1,274 ) Equity-based compensation expense 1,581 — — — 1,581 Net loss — — — (3,891 ) (3,891 ) Other comprehensive income — — 179 — 179 Balance at April 1, 2023 $ 207,489 $ (29,551 ) $ (14 ) $ (57,076 ) $ 120,848 Accumulated Other Comprehensive Income (Loss) The changes in accumulated other comprehensive income (loss) by component for the three months ended March 30, 2024 and April 1, 2023, are as follows: Three Months Ended March 30, 2024 April 1, 2023 Foreign Unrealized holding losses on available-for-sale Total Foreign Unrealized available-for-sale Total (In thousands) Beginning balance $ 159 $ (62 ) $ 97 $ 291 $ (484 ) $ (193 ) Other comprehensive income (loss) before reclassification (96 ) 29 (67 ) 10 169 179 Amounts reclassified from other comprehensive income (loss) — — — — — — Net current-period other comprehensive income (loss) (96 ) 29 (67 ) 10 169 179 Ending balance $ 63 $ (33 ) $ 30 $ 301 $ (315 ) $ (14 ) Stock Repurchase Program On November 21, 2013, Intevac announced that its Board of Directors approved a stock repurchase program authorizing up to $30.0 million in repurchases. On August 20, 2018, Intevac announced that its Board of Directors approved a $10.0 million increase to the original stock repurchase program for an aggregate authorized amount of up to $40.0 million. At March 30, 2024, $10.4 million remains available for future stock repurchases under the repurchase program. Intevac did not make any common stock repurchases during the three months ended March 30, 2024 and April 1, 2023. Intevac records treasury stock purchases under the cost method using the first-in, first-out paid-in paid-in |
Net Loss Per Share
Net Loss Per Share | 3 Months Ended |
Mar. 30, 2024 | |
Earnings Per Share [Abstract] | |
Net Loss Per Share | 11. Net Loss Per Share The following table sets forth the computation of basic and diluted net loss per share. Three Months Ended March 30, 2024 April 1, 2023 (In thousands, except per share amounts) Net loss from continuing operations $ (2,701 ) $ (4,168 ) Net income from discontinued operations, net of tax 1,095 277 Net loss $ (1,606 ) $ (3,891 ) Weighted-average shares – basic 26,522 25,781 Effect of dilutive potential common shares — — Weighted-average shares – diluted 26,522 25,781 Basic and diluted net income (loss) per share: Continuing operations $ (0.10 ) $ (0.16 ) Discontinued operations $ 0.04 $ 0.01 Net loss per share $ (0.06 ) $ (0.15 ) As the Company is in a net loss position, all of the Company’s equity instruments are considered antidilutive. |
Income Taxes
Income Taxes | 3 Months Ended |
Mar. 30, 2024 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | 12. Income Taxes Intevac recorded income tax provisions of $476,000 for the three months ended March 30, 2024 and $386,000 for the three months ended April 1, 2023. The income tax provisions for the three-month periods are based upon estimates of annual income (loss), annual permanent differences and statutory tax rates in the various jurisdictions in which Intevac operates. For the three months ended March 30, 2024, Intevac recorded an income tax provision of $344,000 on the income of its international subsidiaries and recorded $135,000 for withholding taxes on royalties paid to the United States from Intevac’s Singapore subsidiary as a discrete item. For the three months ended April 1, 2023, Intevac recorded an income tax provision of $224,000 on the income of its international subsidiaries and recorded $162,000 for withholding taxes on royalties paid to the United States from Intevac’s Singapore subsidiary as a discrete item. Intevac’s tax rate differs from the applicable statutory rates due primarily to the establishment of a valuation allowance, the utilization of deferred and current credits and the effect of permanent differences and adjustments of prior permanent differences. Intevac’s future effective income tax rate depends on various factors, including the level of Intevac’s projected earnings, the geographic composition of worldwide earnings, tax regulations governing each region, net operating loss carry-forwards, availability of tax credits and the effectiveness of Intevac’s tax planning strategies. Management carefully monitors these factors and timely adjusts the effective income tax rate. Under the Coronavirus Aid, Relief, and Economic Security Act of 2021 (the “CARES Act”), as modified and clarified by the Consolidated Appropriations Act of 2021 and the American Rescue Plan Act of 2021, the Company was eligible for an Employee Retention Credit (“ERC”) subject to certain criteria. The ERC is a payroll tax refund per employee, which was designed by the U.S. Treasury Department to assist businesses that retained employees during the COVID pandemic. During the three months ended March 30, 2024, we amended certain fiscal year 2021 payroll tax filings and applied for a refund equal to $2.4 million of ERC benefits. The refund is recorded within trade and other accounts receivable in our condensed consolidated balance sheet as of March 30, 2024, and as $1.5 million in other income (expense), net and $933,000 in discontinued operations in our condensed consolidated statements of operations for the three months ended March 30, 2024. |
Restructuring And Other Costs,
Restructuring And Other Costs, Net | 3 Months Ended |
Mar. 30, 2024 | |
Restructuring and Related Activities [Abstract] | |
Restructuring and Other Costs, Net | 13. Restructuring and Other Costs, Net During the fourth quarter of fiscal 2021, the Company recorded asset impairment and restructuring charges associated with the sale of the Photonics division including $665,000 in accruals for common area charges associated with an unused space commitment to EOTECH. In consideration of EOTECH’s assumption of certain lease obligations related to the Company’s Santa Clara, California campus, which assumed lease obligations pertain in part to excess space beyond that required by EOTECH’s anticipated operation of the Photonics division, the Company agreed to pay EOTECH the amount of $2.1 million, which was payable in (i) one initial installment of $308,000 on January 10, 2022 and (ii) seven equal quarterly installments of $259,000. The final installment was paid on October 9, 2023. The changes in restructuring reserves, which resulted from other exit costs associated with the Photonics divestiture for the three months ended April 1, 2023 were as follows. Three Months April 1, 2023 (In thousands) Balance at December 31, 2022 $ 318 Provision for restructuring charges associated with Photonics divestiture (a) 3 Cash payments made (81 ) Balance at April 1, 2023 $ 240 (a) Included in loss from discontinued operations (See Note 2). |
Acquisition of Hia, Inc.
Acquisition of Hia, Inc. | 3 Months Ended |
Mar. 30, 2024 | |
Business Combinations [Abstract] | |
Contingent Consideration | 14. Acquisition of Hia, Inc. On August 26, 2022 (the “Closing Date”), the Company completed the acquisition of Hia, Inc., a supplier of magnetic bars, to bring the manufacturing of these magnetic bars in-house The Company determined this transaction represented an asset acquisition as substantially all of the value was in the technology intangible assets of Hia. Contingent consideration is not recorded in an asset acquisition until the contingency is resolved (when the contingent consideration is paid or becomes payable) or when probable and reasonably estimable. The first milestone was achieved and contingent consideration in the amount of $250,000 was paid on January 17, 2023. The technology intangible assets are being amortized on a straight-line basis over a period of 8.3 years. Total amortization expense during the three months ended March 30, 2024 and April 1, 2023 was $34,000 and $34,000, respectively. Annual amortization expense related to the acquired technology intangible assets in each of the succeeding years is estimated to be approximately $102,000 for the remainder of fiscal 2024 and approximately $136,000 per year from fiscal 2025 through fiscal 2030. The following table represents the carrying amount of the Hia technology intangible assets at March 30, 2024 and December 30, 2023 (in thousands): March 30, 2024 December 30, 2023 (In thousands) Gross carrying amount $ 1,132 $ 1,132 Accumulated amortization (212 ) (178 ) Net carrying amount $ 920 $ 954 |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Mar. 30, 2024 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | 15. Commitments and Contingencies From time to time, Intevac may have certain contingent liabilities that arise in the ordinary course of its business activities. Intevac accounts for contingent liabilities when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. Legal Matters From time to time, Intevac receives notification from third parties, including customers and suppliers, seeking indemnification, litigation support, payment of money or other actions in connection with claims made against them. In addition, from time to time, Intevac receives notification from third parties claiming that Intevac may be or is infringing their intellectual property or other rights. Intevac also is subject to various other legal proceedings and claims, both asserted and unasserted, that arise in the ordinary course of business. Although the outcome of these claims and proceedings cannot be predicted with certainty, Intevac does not believe that any existing proceedings or claims will have a material adverse effect on its consolidated financial condition or results of operations. |
Description of Business, Basi_2
Description of Business, Basis of Presentation and Significant Accounting Policy (Policies) | 3 Months Ended |
Mar. 30, 2024 | |
Principles of Consolidation and Basis of Presentation | Principles of Consolidation and Basis of Presentation The condensed consolidated financial statements include the accounts of Intevac, Inc. and its subsidiaries after elimination of inter-company balances and transactions. In the opinion of management, the unaudited interim condensed consolidated financial statements of Intevac included herein have been prepared on a basis consistent with the December 30, 2023 audited consolidated financial statements and include all material adjustments, consisting of normal recurring adjustments, necessary to fairly present the information set forth therein. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. |
Reportable Segment | Reportable Segment During fiscal 2021, we sold the business of one of our reporting segments, Photonics. Therefore, we have one reportable segment remaining. See Note 2 for additional disclosure related to discontinued operations. The remaining segment, Thin Film Equipment (“TFE”), designs, develops and markets vacuum process equipment solutions for high-volume manufacturing of small substrates with precise thin-film properties, such as for the HDD and ADVC markets, as well as other adjacent thin-film markets. The TFE segment also previously designed, developed and marketed manufacturing equipment for the photovoltaic (“PV”) solar cell and advanced semiconductor packaging (“ASP”) industries. In March 2022, the Company’s management realigned its operational focus and eliminated several research and development (“R&D”) programs and product offerings. As part of this realignment effort, the Company ceased its efforts to develop and market several of its manufacturing platforms for the ADVC, PV and ASP industries. |
Government Grants and Credits | Government Grants and Credits Government assistance is recognized when there is reasonable assurance that the Company will comply with the conditions attached to the grant arrangement and the grant will be received. Reimbursements of eligible expenditures pursuant to government assistance programs are recorded when the related costs have been incurred and there is reasonable assurance regarding collection of the claim. Grant claims not settled by the balance sheet date are recorded as receivables, provided their receipt is reasonably assured. The determination of the amount of the claim, and accordingly the receivable amount, requires management to make calculations based on its interpretation of eligible expenditures in accordance with the terms of the programs. The reimbursement claims submitted by the Company are subject to review by the relevant government agencies. During the three months ended March 30, 2024, we amended certain fiscal year 2021 payroll tax filings and applied for a refund equal to $2.4 million of Employee Retention Credit (“ERC”) benefits from the U.S. government. The refund is recorded within trade and other accounts receivable in our condensed consolidated balance sheet as of March 30, 2024, and as $1.5 million in other income (expense), net and $933,000 in discontinued operations in our condensed consolidated statements of operations for the three months ended March 30, 2024. (See Note 12. Income Taxes.) |
Divestiture and Discontinued _2
Divestiture and Discontinued Operations (Tables) | 3 Months Ended |
Mar. 30, 2024 | |
Disposal Group, Including Discontinued Operation, Balance Sheet Disclosures [Abstract] | |
Summary of components discontinued operations related photonics segment | The key components from discontinued operations related to the Photonics segment are as follows: Three Months Ended March 30, April 1, (In thousands) Operating expenses: Selling, general and administrative $ (162 ) $ (277 ) Total operating expenses (162 ) (277 ) Operating income – discontinued operations 162 277 Other income (expense) – discontinued operations 933 — Income from discontinued operations before provision for income taxes 1,095 277 Provision for income taxes — — Net income from discontinued operations, net of taxes $ 1,095 $ 277 |
Summary of cash flow and noncash information related to discontinued operations | The following table presents cash flow and non-cash Three Months Ended March 30, April 1, 2023 (In thousands) Equity-based compensation $ — $ (260 ) |
Revenue (Tables)
Revenue (Tables) | 3 Months Ended |
Mar. 30, 2024 | |
Revenue from Contract with Customer [Abstract] | |
Disaggregation of Revenue from Contracts with Customers | The following tables represent a disaggregation of revenue from contracts with customers for the three months ended March 30, 2024 and April 1, 2023. Major Products and Service Lines Three Months Ended Three Months Ended April 1, 2023 (In thousands) HDD HDD PV Total Systems, upgrades and spare parts $ 8,119 $ 10,517 $ 18 $ 10,535 Field service 1,512 1,007 — 1,007 Total net revenues $ 9,631 $ 11,524 $ 18 $ 11,542 Revenue by Geographic Region Three Months Ended March 30, April 1, 2023 (In thousands) United States $ 482 $ 1,614 Asia 9,149 9,928 Total net revenues $ 9,631 $ 11,542 Timing of Revenue Recognition Three Months Ended March 30, April 1, 2023 (In thousands) Products transferred at a point in time $ 9,631 $ 11,542 Products and services transferred over time — — Total net revenues $ 9,631 $ 11,542 |
Changes in Contract Assets and Contract Liabilities | The following table reflects the changes in our contract assets, which we classify as accounts receivable, unbilled, and our contract liabilities, which we classify as deferred revenue and customer advances, for the three months ended March 30 2024. March 30, December 30, Three Months Change (In thousands) Contract assets: Accounts receivable, unbilled $ 884 $ 393 $ 491 Contract liabilities: Deferred revenue $ 476 $ 376 $ 100 Customer advances 24,526 21,889 2,637 $ 25,002 $ 22,265 $ 2,737 |
Inventories (Tables)
Inventories (Tables) | 3 Months Ended |
Mar. 30, 2024 | |
Inventory Disclosure [Abstract] | |
Summary of Inventories | Inventories are stated at the lower of average cost or net realizable value and consist of the following: March 30, 2024 December 30, 2023 (In thousands) Raw materials $ 35,755 $ 37,346 Work-in-progress 10,053 6,449 $ 45,808 $ 43,795 |
Equity-Based Compensation (Tabl
Equity-Based Compensation (Tables) | 3 Months Ended |
Mar. 30, 2024 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Effect of Recording Equity-Based Compensation | Compensation Expense The effect of recording equity-based compensation for the three months ended March 30, 2024 and April 1, 2023 was as follows: Three Months Ended March 30, April 1, (In thousands) Equity-based compensation by type of award: Stock options $ — $ (13 ) RSUs 533 599 PRSUs 91 798 ESPP purchase rights 137 197 Total equity-based compensation $ 761 $ 1,581 |
Summary of Stock Option Activity | Option activity as of March 30, 2024 and changes during the three months ended March 30, 2024 were as follows: Shares Weighted-Average Options outstanding at December 30, 2023 142,000 $ 6.57 Options cancelled and forfeited (9,000 ) $ 7.71 Options outstanding at March 30, 2024 133,000 $ 6.50 Options exercisable at March 30, 2024 133,000 $ 6.50 |
Summary of Restricted Stock Units Activity | A summary of the RSU activity is as follows: Shares Weighted-Average Grant Date Fair Value Non-vested 915,087 $ 4.89 Granted 51,925 $ 3.97 Vested (67,263 ) $ 5.39 Cancelled and forfeited (8,654 ) $ 5.62 Non-vested 891,095 $ 4.79 |
Employee Stock Purchase Rights Weighted-Average Assumptions | Intevac estimated the weighted-average fair value of ESPP purchase rights using the following weighted-average assumptions: Three Months Ended March 30, April 1, ESPP Purchase Rights: Weighted-average fair value of grants per share $ 1.41 $ 2.23 Expected volatility 47.81 % 34.20 % Risk-free interest rate 4.52 % 4.47 % Expected term of purchase rights (in years) 1.0 1.0 Dividend yield None None |
Performance Based Restricted Stock Units PRSUs | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Summary of Restricted Stock Units Activity | A summary of the PRSU activity is as follows: Shares Weighted-Average Grant Date Fair Value Non-vested 1,160,293 $ 4.04 Vested — $ — Cancelled and forfeited — $ — Non-vested 1,160,293 $ 4.04 |
Warranty (Tables)
Warranty (Tables) | 3 Months Ended |
Mar. 30, 2024 | |
Guarantees [Abstract] | |
Schedule of Product Warranty Liability | The following table displays the activity in the warranty provision account for the three months ended March 30, 2024 and April 1, 2023. Three Months Ended March 30, 2024 April 1, 2023 (In thousands) Opening balance $ 205 $ 163 Expenditures incurred under warranties (36 ) (97 ) Accruals for product warranties issued during the reporting period 38 100 Adjustments to previously existing warranty accruals (48 ) 11 Closing balance $ 159 $ 177 The following table displays the balance sheet classification of the warranty provision account at March 30, 2024 and at December 30, 2023. March 30, December 30, (In thousands) Other accrued liabilities $ 145 $ 184 Other long-term liabilities 14 21 Total warranty provision $ 159 $ 205 |
Cash, Cash Equivalents and In_2
Cash, Cash Equivalents and Investments (Tables) | 3 Months Ended |
Mar. 30, 2024 | |
Cash Flow Hedges Derivative Instruments at Fair Value, Net [Abstract] | |
Cash, Cash Equivalents and Short-Term Investments and Long-Term Investments | Cash and cash equivalents, short-term investments and long-term investments consist of: March 30, 2024 Amortized Cost Unrealized Unrealized Fair Value (In thousands) Cash and cash equivalents: Cash $ 15,100 $ — $ — $ 15,100 Money market funds 15,183 — — 15,183 Commercial paper 14,474 — 6 14,468 U.S. treasury securities 999 — — 999 Total cash and cash equivalents $ 45,756 $ — $ 6 $ 45,750 Short-term investments: Certificates of deposit $ 300 $ — $ — $ 300 Commercial paper 6,610 — 3 6,607 Corporate bonds and medium-term notes 5,491 — 18 5,473 Municipal bonds 221 — 2 219 U.S. treasury and agency securities 5,500 — 5 5,495 Total short-term investments $ 18,122 $ — $ 28 $ 18,094 Long-term investments: Asset backed securities $ 206 $ — $ 2 $ 204 Corporate bonds and medium-term notes 715 3 — 718 Total long-term investments $ 921 $ 3 $ 2 $ 922 Total cash, cash equivalents, and investments $ 64,799 $ 3 $ 36 $ 64,766 December 30, 2023 Amortized Cost Unrealized Unrealized Fair Value (In thousands) Cash and cash equivalents: Cash $ 19,050 $ — $ — $ 19,050 Money market funds 15,090 — — 15,090 Commercial paper 14,659 — 4 14,655 U.S. treasury securities 2,646 — — 2,646 Total cash and cash equivalents $ 51,445 $ — $ 4 $ 51,441 Short-term investments: Asset backed securities $ 12 $ — $ — $ 12 Certificates of deposit 1,850 — — 1,850 Commercial paper 3,506 — 1 3,505 Corporate bonds and medium-term notes 5,373 — 36 5,337 Municipal bonds 221 — 2 219 U.S. treasury and agency securities 6,498 1 17 6,482 Total short-term investments $ 17,460 $ 1 $ 56 $ 17,405 Long-term investments: Asset backed securities $ 460 $ — $ 4 $ 456 Corporate bonds and medium-term notes 2,230 1 — 2,231 Total long-term investments $ 2,690 $ 1 $ 4 $ 2,687 Total cash, cash equivalents, and investments $ 71,595 $ 2 $ 64 $ 71,533 |
Contractual Maturities of Available-for-Sale Securities | The contractual maturities of investment securities at March 30, 2024 are presented in the following table. Amortized Cost Fair Value (In thousands) Due in one year or less $ 48,778 $ 48,744 Due after one through five years 921 922 $ 49,699 $ 49,666 |
Fair Market Value of Investments with Unrealized Losses Not Deemed to be Other-Than Temporarily Impaired | The following table provides the fair market value of Intevac’s investments with unrealized losses that are not deemed to be other-than temporarily impaired as of March 30, 2024. March 30, 2024 In Loss Position for Less than 12 Months In Loss Position for Greater than 12 Months Fair Value Gross Unrealized Fair Value Gross Unrealized (In thousands) Asset backed securities $ — $ — $ 204 $ 2 Commercial paper 21,075 9 — — Corporate bonds and medium-term notes 2,007 5 3,466 13 Municipal bonds — — 219 2 U.S. treasury securities — — 1,995 5 $ 23,082 $ 14 $ 5,884 $ 22 |
Fair Value Hierarchy of Available-for-Sale Securities Measured at Fair Value on Recurring Basis | The following table represents the fair value hierarchy of Intevac’s investment securities measured at fair value on a recurring basis as of March 30, 2024. Fair Value Measurements at March 30, 2024 Total Level 1 Level 2 (In thousands) Recurring fair value measurements: Investment securities Money market funds $ 15,183 $ 15,183 $ — U.S. treasury and agency securities 6,494 2,994 3,500 Asset backed securities 204 — 204 Certificates of deposit 300 — 300 Commercial paper 21,075 — 21,075 Corporate bonds and medium-term notes 6,191 — 6,191 Municipal bonds 219 — 219 Total recurring fair value measurements $ 49,666 $ 18,177 $ 31,489 |
Equity (Tables)
Equity (Tables) | 3 Months Ended |
Mar. 30, 2024 | |
Equity [Abstract] | |
Schedule of Changes in Stockholders' Equity | The changes in stockholders’ equity by component for the three months ended March 30, 2024 and April 1, 2023, are as follows (in thousands): Three Months Ended March 30, 2024 Common Paid-in Treasury Accumulated Accumulated Total Balance at December 30, 2023 $ 210,346 $ (29,551 ) $ 97 $ (65,375 ) $ 115,517 Common stock issued under employee plans 462 — — — 462 Shares withheld for net share settlement of RSUs (144 ) — — — (144 ) Equity-based compensation expense 761 — — — 761 Net loss — — — (1,606 ) (1,606 ) Other comprehensive loss — — (67 ) — (67 ) Balance at March 30, 2024 $ 211,425 $ (29,551 ) $ 30 $ (66,981 ) $ 114,923 Three Months Ended April 1, 2023 Common Paid-in Treasury Accumulated Accumulated Total Balance at December 31, 2022 $ 206,381 $ (29,551 ) $ (193 ) $ (53,185 ) $ 123,452 Common stock issued under employee plans 801 — — — 801 Shares withheld for net share settlement of RSUs (1,274 ) — — — (1,274 ) Equity-based compensation expense 1,581 — — — 1,581 Net loss — — — (3,891 ) (3,891 ) Other comprehensive income — — 179 — 179 Balance at April 1, 2023 $ 207,489 $ (29,551 ) $ (14 ) $ (57,076 ) $ 120,848 |
Changes in Accumulated Other Comprehensive Income by Component | The changes in accumulated other comprehensive income (loss) by component for the three months ended March 30, 2024 and April 1, 2023, are as follows: Three Months Ended March 30, 2024 April 1, 2023 Foreign Unrealized holding losses on available-for-sale Total Foreign Unrealized available-for-sale Total (In thousands) Beginning balance $ 159 $ (62 ) $ 97 $ 291 $ (484 ) $ (193 ) Other comprehensive income (loss) before reclassification (96 ) 29 (67 ) 10 169 179 Amounts reclassified from other comprehensive income (loss) — — — — — — Net current-period other comprehensive income (loss) (96 ) 29 (67 ) 10 169 179 Ending balance $ 63 $ (33 ) $ 30 $ 301 $ (315 ) $ (14 ) |
Net Loss Per Share (Tables)
Net Loss Per Share (Tables) | 3 Months Ended |
Mar. 30, 2024 | |
Earnings Per Share [Abstract] | |
Computation of Basic and Diluted Net Income Per Share | The following table sets forth the computation of basic and diluted net loss per share. Three Months Ended March 30, 2024 April 1, 2023 (In thousands, except per share amounts) Net loss from continuing operations $ (2,701 ) $ (4,168 ) Net income from discontinued operations, net of tax 1,095 277 Net loss $ (1,606 ) $ (3,891 ) Weighted-average shares – basic 26,522 25,781 Effect of dilutive potential common shares — — Weighted-average shares – diluted 26,522 25,781 Basic and diluted net income (loss) per share: Continuing operations $ (0.10 ) $ (0.16 ) Discontinued operations $ 0.04 $ 0.01 Net loss per share $ (0.06 ) $ (0.15 ) |
Restructuring Charges (Tables)
Restructuring Charges (Tables) | 3 Months Ended |
Mar. 30, 2024 | |
Restructuring and Related Activities [Abstract] | |
Changes in Restructuring Reserves | The changes in restructuring reserves, which resulted from other exit costs associated with the Photonics divestiture for the three months ended April 1, 2023 were as follows. Three Months April 1, 2023 (In thousands) Balance at December 31, 2022 $ 318 Provision for restructuring charges associated with Photonics divestiture (a) 3 Cash payments made (81 ) Balance at April 1, 2023 $ 240 (a) Included in loss from discontinued operations (See Note 2). |
Acquisition of Hia, Inc (Tables
Acquisition of Hia, Inc (Tables) | 3 Months Ended |
Mar. 30, 2024 | |
Business Combinations [Abstract] | |
Schedule of Tabular Form of Finite Lived Technology Intangible Assets | The following table represents the carrying amount of the Hia technology intangible assets at March 30, 2024 and December 30, 2023 (in thousands): March 30, 2024 December 30, 2023 (In thousands) Gross carrying amount $ 1,132 $ 1,132 Accumulated amortization (212 ) (178 ) Net carrying amount $ 920 $ 954 |
Description of Business, Basi_3
Description of Business, Basis of Presentation and Significant Accounting Policy - Additional Information (Detail) - Employee Retention Credit | 3 Months Ended |
Mar. 30, 2024 USD ($) | |
Other Nonoperating Income (Expense) | |
Summary Of Significant Accounting Policies [Line Items] | |
Government assistance recognized | $ 1,500,000 |
Discontinued Operations | |
Summary Of Significant Accounting Policies [Line Items] | |
Government assistance recognized | 933,000 |
Trade and Other Accounts Receivable Current | |
Summary Of Significant Accounting Policies [Line Items] | |
Government assistance receivable current | $ 2,400,000 |
Divestiture and Discontinued _3
Divestiture and Discontinued Operations - Summary of Components Discontinued Operations Related to Photonics Segment (Detail) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 30, 2024 | Apr. 01, 2023 | |
Operating expenses: | ||
Income from discontinued operations before provision for income taxes | $ (2,225) | $ (3,782) |
Provision for income taxes | 476 | 386 |
Net income from discontinued operations, net of taxes | 1,095 | 277 |
Photonics | ||
Operating expenses: | ||
Operating Expenses | (162) | (277) |
Operating income – discontinued operations | 162 | 277 |
Other income (expense)—discontinued operations | 933 | 0 |
Income from discontinued operations before provision for income taxes | 1,095 | 277 |
Provision for income taxes | 0 | 0 |
Net income from discontinued operations, net of taxes | 1,095 | 277 |
Photonics | Selling, general and administrative | ||
Operating expenses: | ||
Operating Expenses | $ (162) | $ (277) |
Divestiture and Discontinued _4
Divestiture and Discontinued Operations - Summary of Cash Flow and Non-cash Information Related to Discontinued Operations (Detail) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 30, 2024 | Apr. 01, 2023 | |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||
Equity-based compensation | $ 0 | $ (260) |
Divestiture and Discontinued _5
Divestiture and Discontinued Operations - Additional Information (Detail) - EOTECH LLC - USD ($) | 3 Months Ended | |||||
Mar. 30, 2024 | Apr. 01, 2023 | Dec. 31, 2024 | Dec. 30, 2023 | Dec. 31, 2022 | Dec. 30, 2021 | |
Accounts Receivable, after Allowance for Credit Loss, Current | $ 10,000 | $ 62,000 | ||||
Shared Services Agreement | ||||||
Proceeds from Fees Received | $ 37,000 | $ 25,000 | ||||
Photonics | ||||||
Cash | $ 70,000,000 | |||||
Earnout payment | $ 30,000,000 | $ 30,000,000 | ||||
Photonics | Subsequent Event | ||||||
Earnout payment | $ 14,000,000 |
Revenue - Disaggregation of Rev
Revenue - Disaggregation of Revenue from Contracts with Customers (Detail) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 30, 2024 | Apr. 01, 2023 | |
Disaggregation of Revenue [Line Items] | ||
Total net revenues | $ 9,631 | $ 11,542 |
TFE | ||
Disaggregation of Revenue [Line Items] | ||
Total net revenues | 11,542 | |
TFE | Systems, Upgrades and Spare Parts | ||
Disaggregation of Revenue [Line Items] | ||
Total net revenues | 10,535 | |
TFE | Field Service | ||
Disaggregation of Revenue [Line Items] | ||
Total net revenues | 1,007 | |
HDD | TFE | ||
Disaggregation of Revenue [Line Items] | ||
Total net revenues | 9,631 | 11,524 |
HDD | TFE | Systems, Upgrades and Spare Parts | ||
Disaggregation of Revenue [Line Items] | ||
Total net revenues | 8,119 | 10,517 |
HDD | TFE | Field Service | ||
Disaggregation of Revenue [Line Items] | ||
Total net revenues | $ 1,512 | 1,007 |
PV | TFE | ||
Disaggregation of Revenue [Line Items] | ||
Total net revenues | 18 | |
PV | TFE | Systems, Upgrades and Spare Parts | ||
Disaggregation of Revenue [Line Items] | ||
Total net revenues | 18 | |
PV | TFE | Field Service | ||
Disaggregation of Revenue [Line Items] | ||
Total net revenues | $ 0 |
Revenue - Primary Geography Mar
Revenue - Primary Geography Markets (Detail) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 30, 2024 | Apr. 01, 2023 | |
Disaggregation of Revenue [Line Items] | ||
Total net revenues | $ 9,631 | $ 11,542 |
Products Transferred at a Point in Time | ||
Disaggregation of Revenue [Line Items] | ||
Total net revenues | 9,631 | 11,542 |
Products and Services Transferred Over Time | ||
Disaggregation of Revenue [Line Items] | ||
Total net revenues | 0 | 0 |
United States | ||
Disaggregation of Revenue [Line Items] | ||
Total net revenues | 482 | 1,614 |
Asia | ||
Disaggregation of Revenue [Line Items] | ||
Total net revenues | $ 9,149 | $ 9,928 |
Revenue - Changes in Contract A
Revenue - Changes in Contract Assets and Contract Liabilities (Detail) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 30, 2024 | Dec. 30, 2023 | |
Contract liabilities: | ||
Contract liabilities | $ 25,002 | $ 22,265 |
Contract liabilities: | ||
Change in contract liabilities | 2,737 | |
Accounts Receivable, Unbilled | ||
Contract assets: | ||
Contract assets | 884 | 393 |
Contract assets: | ||
Change in contract assets | 491 | |
Deferred Revenue | ||
Contract liabilities: | ||
Contract liabilities | 476 | 376 |
Contract liabilities: | ||
Change in contract liabilities | 100 | |
Customer Advances | ||
Contract liabilities: | ||
Contract liabilities | 24,526 | $ 21,889 |
Contract liabilities: | ||
Change in contract liabilities | $ 2,637 |
Revenue - Additional Informatio
Revenue - Additional Information (Detail) | 3 Months Ended | |||
Mar. 30, 2024 USD ($) Installment | Dec. 30, 2023 USD ($) | Sep. 30, 2023 USD ($) | May 01, 2023 USD ($) | |
Revenue From Contract With Customers [Line Items] | ||||
Number of installments | Installment | 3 | |||
Revenue remaining performance obligation | $ 53,100,000 | |||
Revenue performance obligation, description of timing | we also refer to as total backlog. We expect to recognize approximately 55.4% of our remaining performance obligations as revenue in 2024 and 44.6% in 2025. | |||
Inventory, Net of Allowances, Customer Advances and Progress Billings | $ 444,000 | |||
Received customer advances associated with the cancelled order | $ 19,100,000 | |||
Cancellation Order Received And Obligation Thereof | $ 11,400,000 | $ 54,600,000 | ||
Accounts Receivable, Unbilled | ||||
Revenue From Contract With Customers [Line Items] | ||||
Change in contract assets | $ 491,000 | |||
TFE | Accounts Receivable, Unbilled | ||||
Revenue From Contract With Customers [Line Items] | ||||
Change in contract assets | 491,000 | |||
TFE | Deferred Revenue | ||||
Revenue From Contract With Customers [Line Items] | ||||
Contract with customer liability revenue recognized | $ 66,000,000,000 |
Revenue - Additional Informat_2
Revenue - Additional Information (Detail 1) | Dec. 31, 2025 | Dec. 31, 2024 |
Scenario Forecast | ||
Revenue From Contract With Customers [Line Items] | ||
Revenue, remaining performance obligation, percentage | 44.60% | 55.40% |
Inventories - Summary of Invent
Inventories - Summary of Inventories (Detail) - USD ($) $ in Thousands | Mar. 30, 2024 | Dec. 30, 2023 |
Inventory Disclosure [Abstract] | ||
Raw materials | $ 35,755 | $ 37,346 |
Work-in-progress | 10,053 | 6,449 |
Inventories | $ 45,808 | $ 43,795 |
Inventories - Additional Inform
Inventories - Additional Information (Detail) - USD ($) $ in Millions | Mar. 30, 2024 | Dec. 30, 2023 | May 01, 2023 |
Inventory Disclosure [Abstract] | |||
Cancellation order received and obligation thereof | $ 11.4 | $ 54.6 | |
Received customer advances associated with the cancelled order | $ 19.1 | ||
Inventory to take delivery | $ 11.8 | ||
Inventory reimburse | $ 4 |
Equity-Based Compensation - Add
Equity-Based Compensation - Additional information (Detail) - USD ($) | 3 Months Ended | 12 Months Ended | |||
Jan. 19, 2022 | Mar. 30, 2024 | Apr. 01, 2023 | Dec. 30, 2023 | Dec. 31, 2022 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Purchase of common stock through payroll deductions | 85% | ||||
Offering periods | 2 years | ||||
Maximum employee salary withholdings for purchase of common stock under the terms of the ESPP | 50% | ||||
Purchase intervals of a series | 6 months | ||||
Stock issued under Employee Stock Purchase Plans | 153,595 | ||||
Employee stock obligation amount | $ 25,000 | ||||
Equity-based compensation | 761,000 | $ 1,581,000 | |||
Discontinued Operations | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Equity-based compensation | 260,000 | ||||
Inducement Plan | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Issuance of common stock pursuant to awards granted | 1,200,000 | ||||
Performance Based Restricted Stock Units PRSUs | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Equity-based compensation | $ 91,000 | $ 798,000 | |||
Performance Based Restricted Stock Units PRSUs | Inducement Plan | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Share based compensation by share based award vesting period | 3 years | 3 years |
Equity-Based Compensation - Eff
Equity-Based Compensation - Effect of Recording Equity-Based Compensation (Detail) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 30, 2024 | Apr. 01, 2023 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Equity-based compensation | $ 761 | $ 1,581 |
Stock Options | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Equity-based compensation | 0 | (13) |
Restricted Stock Units (RSUs) | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Equity-based compensation | 533 | 599 |
Performance Based Restricted Stock Units PRSUs | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Equity-based compensation | 91 | 798 |
ESPP purchase rights | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Equity-based compensation | $ 137 | $ 197 |
Equity-Based Compensation - Opt
Equity-Based Compensation - Option Activity and Changes (Detail) | 3 Months Ended |
Mar. 30, 2024 $ / shares shares | |
Shares | |
Options outstanding at December 30, 2023 | shares | 142,000 |
Options cancelled and forfeited | shares | (9,000) |
Options outstanding at March 30, 2024 | shares | 133,000 |
Options exercisable at March 30, 2024 | shares | 133,000 |
Weighted-Average Exercise Price | |
Options outstanding at December 30, 2023 | $ / shares | $ 6.57 |
Options cancelled and forfeited | $ / shares | 7.71 |
Options outstanding at March 30, 2024 | $ / shares | 6.5 |
Options exercisable at March 30, 2024 | $ / shares | $ 6.5 |
Equity-Based Compensation - Wei
Equity-Based Compensation - Weighted-Average Fair Value of Stock Options and Employee Stock Purchase Rights using Weighted-Average Assumptions (Detail) - Stock Purchase Rights - $ / shares | 3 Months Ended | |
Mar. 30, 2024 | Apr. 01, 2023 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Weighted-average fair value of grants per share | $ 1.41 | $ 2.23 |
Expected volatility | 47.81% | 34.20% |
Risk-free interest rate | 4.52% | 4.47% |
Expected term of purchase rights (in years) | 1 year | 1 year |
Dividend yield | 0% | 0% |
Equity-Based Compensation - Sum
Equity-Based Compensation - Summary of Restricted Stock Units Activity (Detail) | 3 Months Ended |
Mar. 30, 2024 $ / shares shares | |
Restricted Stock Units (RSUs) | |
Shares | |
Non-vested RSUs at December 30, 2023 | shares | 915,087 |
Granted | shares | 51,925 |
Vested | shares | (67,263) |
Cancelled and forfeited | shares | (8,654) |
Non-vested RSUs at March 30, 2024 | shares | 891,095 |
Weighted Average Grant Date Fair Value | |
Non-vested RSUs at December 30, 2023 | $ / shares | $ 4.89 |
Granted | $ / shares | 3.97 |
Vested | $ / shares | 5.39 |
Cancelled and forfeited | $ / shares | 5.62 |
Non-vested RSUs at March 30, 2024 | $ / shares | $ 4.79 |
Performance Based Restricted Stock Units PRSUs | |
Shares | |
Non-vested RSUs at December 30, 2023 | shares | 1,160,293 |
Vested | shares | 0 |
Cancelled and forfeited | shares | 0 |
Non-vested RSUs at March 30, 2024 | shares | 1,160,293 |
Weighted Average Grant Date Fair Value | |
Non-vested RSUs at December 30, 2023 | $ / shares | $ 4.04 |
Vested | $ / shares | 0 |
Cancelled and forfeited | $ / shares | 0 |
Non-vested RSUs at March 30, 2024 | $ / shares | $ 4.04 |
Warranty - Additional Informati
Warranty - Additional Information (Detail) | 3 Months Ended |
Mar. 30, 2024 | |
Guarantees [Abstract] | |
Minimum product warranty range | 12 months |
Maximum product warranty range | 24 months |
Warranty - Schedule of Warranty
Warranty - Schedule of Warranty Provision Account (Detail) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 30, 2024 | Apr. 01, 2023 | |
Guarantees [Abstract] | ||
Opening balance | $ 205 | $ 163 |
Expenditures incurred under warranties | (36) | (97) |
Accruals for product warranties issued during the reporting period | 38 | 100 |
Adjustments to previously existing warranty accruals | (48) | 11 |
Closing balance | $ 159 | $ 177 |
Warranty - Balance Sheet Classi
Warranty - Balance Sheet Classification of Warranty Provision Account (Detail) - USD ($) $ in Thousands | Mar. 30, 2024 | Dec. 30, 2023 | Apr. 01, 2023 | Dec. 31, 2022 |
Guarantees [Abstract] | ||||
Other accrued liabilities | $ 145 | $ 184 | ||
Other long-term liabilities | 14 | 21 | ||
Total warranty provision | $ 159 | $ 205 | $ 177 | $ 163 |
Guarantees - Additional Informa
Guarantees - Additional Information (Detail) | Mar. 30, 2024 USD ($) |
Guarantees [Abstract] | |
Letters of credit and bank guarantees outstanding, amount | $ 700,000 |
Letters of credit and bank guarantees collateralized by restricted cash | $ 700,000 |
Cash, Cash Equivalents and In_3
Cash, Cash Equivalents and Investments - Cash, Cash Equivalents and Short-Term Investments and Long-Term Investments (Detail) - USD ($) $ in Thousands | Mar. 30, 2024 | Dec. 30, 2023 |
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | $ 64,799 | $ 71,595 |
Unrealized Holding Gains | 3 | 2 |
Unrealized Holding Losses | 36 | 64 |
Fair Value | 64,766 | 71,533 |
Cash and Cash Equivalents | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 45,756 | 51,445 |
Unrealized Holding Gains | 0 | 0 |
Unrealized Holding Losses | 6 | 4 |
Fair Value | 45,750 | 51,441 |
Cash and Cash Equivalents | Cash | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 15,100 | 19,050 |
Unrealized Holding Gains | 0 | 0 |
Unrealized Holding Losses | 0 | 0 |
Fair Value | 15,100 | 19,050 |
Cash and Cash Equivalents | Money market funds | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 15,183 | 15,090 |
Unrealized Holding Gains | 0 | 0 |
Unrealized Holding Losses | 0 | 0 |
Fair Value | 15,183 | 15,090 |
Cash and Cash Equivalents | Commercial paper | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 14,474 | 14,659 |
Unrealized Holding Gains | 0 | 0 |
Unrealized Holding Losses | 6 | 4 |
Fair Value | 14,468 | 14,655 |
Cash and Cash Equivalents | U.S. treasury securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 999 | 2,646 |
Unrealized Holding Gains | 0 | 0 |
Unrealized Holding Losses | 0 | 0 |
Fair Value | 999 | 2,646 |
Short-term Investments | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 18,122 | 17,460 |
Unrealized Holding Gains | 0 | 1 |
Unrealized Holding Losses | 28 | 56 |
Fair Value | 18,094 | 17,405 |
Short-term Investments | Asset backed securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 12 | |
Unrealized Holding Gains | 0 | |
Unrealized Holding Losses | 0 | |
Fair Value | 12 | |
Short-term Investments | Corporate bonds and medium-term notes | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 5,491 | 5,373 |
Unrealized Holding Gains | 0 | 0 |
Unrealized Holding Losses | 18 | 36 |
Fair Value | 5,473 | 5,337 |
Short-term Investments | Municipal bonds | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 221 | 221 |
Unrealized Holding Gains | 0 | 0 |
Unrealized Holding Losses | 2 | 2 |
Fair Value | 219 | 219 |
Short-term Investments | U.S. treasury and agency securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 5,500 | 6,498 |
Unrealized Holding Gains | 0 | 1 |
Unrealized Holding Losses | 5 | 17 |
Fair Value | 5,495 | 6,482 |
Short-term Investments | Certificates of deposit | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 300 | 1,850 |
Unrealized Holding Gains | 0 | 0 |
Unrealized Holding Losses | 0 | 0 |
Fair Value | 300 | 1,850 |
Short-term Investments | Commercial paper | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 6,610 | 3,506 |
Unrealized Holding Gains | 0 | 0 |
Unrealized Holding Losses | 3 | 1 |
Fair Value | 6,607 | 3,505 |
Long-term Investments | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 921 | 2,690 |
Unrealized Holding Gains | 3 | 1 |
Unrealized Holding Losses | 2 | 4 |
Fair Value | 922 | 2,687 |
Long-term Investments | Asset backed securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 206 | 460 |
Unrealized Holding Gains | 0 | 0 |
Unrealized Holding Losses | 2 | 4 |
Fair Value | 204 | 456 |
Long-term Investments | Corporate bonds and medium-term notes | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 715 | 2,230 |
Unrealized Holding Gains | 3 | 1 |
Unrealized Holding Losses | 0 | 0 |
Fair Value | $ 718 | $ 2,231 |
Cash, Cash Equivalents and In_4
Cash, Cash Equivalents and Investments - Contractual Maturities of Available-For-Sale Securities (Detail) $ in Thousands | Mar. 30, 2024 USD ($) |
Investments Debt And Equity Securities [Abstract] | |
Amortized Cost, Due in one year or less | $ 48,778 |
Amortized Cost, Due after one through five years | 921 |
Amortized Cost | 49,699 |
Fair Value, Due in one year or less | 48,744 |
Fair Value, Due after one through five years | 922 |
Fair Value | $ 49,666 |
Cash, Cash Equivalents and In_5
Cash, Cash Equivalents and Investments - Fair Market Value of Investments with Unrealized Losses Not Deemed to be Other-Than Temporarily Impaired (Detail) $ in Thousands | Mar. 30, 2024 USD ($) |
Debt Securities, Available-for-sale [Line Items] | |
Unrealized Loss Position, Less than 12 Months, Fair Value | $ 23,082 |
Unrealized Loss Position, Less than 12 Months, Gross Unrealized Losses | 14 |
Unrealized Loss Position, Greater than 12 Months, Fair Value | 5,884 |
Unrealized Loss Position, Greater than 12 Months, Gross Unrealized Losses | 22 |
Commercial paper | |
Debt Securities, Available-for-sale [Line Items] | |
Unrealized Loss Position, Less than 12 Months, Fair Value | 21,075 |
Unrealized Loss Position, Less than 12 Months, Gross Unrealized Losses | 9 |
Unrealized Loss Position, Greater than 12 Months, Fair Value | 0 |
Unrealized Loss Position, Greater than 12 Months, Gross Unrealized Losses | 0 |
Asset backed securities | |
Debt Securities, Available-for-sale [Line Items] | |
Unrealized Loss Position, Less than 12 Months, Fair Value | 0 |
Unrealized Loss Position, Less than 12 Months, Gross Unrealized Losses | 0 |
Unrealized Loss Position, Greater than 12 Months, Fair Value | 204 |
Unrealized Loss Position, Greater than 12 Months, Gross Unrealized Losses | 2 |
Corporate bonds and medium-term notes | |
Debt Securities, Available-for-sale [Line Items] | |
Unrealized Loss Position, Less than 12 Months, Fair Value | 2,007 |
Unrealized Loss Position, Less than 12 Months, Gross Unrealized Losses | 5 |
Unrealized Loss Position, Greater than 12 Months, Fair Value | 3,466 |
Unrealized Loss Position, Greater than 12 Months, Gross Unrealized Losses | 13 |
Municipal bonds | |
Debt Securities, Available-for-sale [Line Items] | |
Unrealized Loss Position, Less than 12 Months, Fair Value | 0 |
Unrealized Loss Position, Less than 12 Months, Gross Unrealized Losses | 0 |
Unrealized Loss Position, Greater than 12 Months, Fair Value | 219 |
Unrealized Loss Position, Greater than 12 Months, Gross Unrealized Losses | 2 |
U.S. treasury securities | |
Debt Securities, Available-for-sale [Line Items] | |
Unrealized Loss Position, Less than 12 Months, Fair Value | 0 |
Unrealized Loss Position, Less than 12 Months, Gross Unrealized Losses | 0 |
Unrealized Loss Position, Greater than 12 Months, Fair Value | 1,995 |
Unrealized Loss Position, Greater than 12 Months, Gross Unrealized Losses | $ 5 |
Cash, Cash Equivalents and In_6
Cash, Cash Equivalents and Investments - Fair Value Hierarchy of Available-for-Sale Securities Measured at Fair Value on Recurring Basis (Detail) $ in Thousands | Mar. 30, 2024 USD ($) |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |
Total recurring fair value measurements | $ 49,666 |
Fair Value, Measurements, Recurring | |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |
Total recurring fair value measurements | 49,666 |
Fair Value, Measurements, Recurring | Money market funds | |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |
Total recurring fair value measurements | 15,183 |
Fair Value, Measurements, Recurring | Certificates of deposit | |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |
Total recurring fair value measurements | 300 |
Fair Value, Measurements, Recurring | Commercial paper | |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |
Total recurring fair value measurements | 21,075 |
Fair Value, Measurements, Recurring | U.S. treasury and agency securities | |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |
Total recurring fair value measurements | 6,494 |
Fair Value, Measurements, Recurring | Corporate bonds and medium-term notes | |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |
Total recurring fair value measurements | 6,191 |
Fair Value, Measurements, Recurring | Municipal bonds | |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |
Total recurring fair value measurements | 219 |
Fair Value, Measurements, Recurring | Asset backed securities | |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |
Total recurring fair value measurements | 204 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |
Total recurring fair value measurements | 18,177 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | Money market funds | |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |
Total recurring fair value measurements | 15,183 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | Certificates of deposit | |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |
Total recurring fair value measurements | 0 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | Commercial paper | |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |
Total recurring fair value measurements | 0 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | U.S. treasury and agency securities | |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |
Total recurring fair value measurements | 2,994 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | Corporate bonds and medium-term notes | |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |
Total recurring fair value measurements | 0 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | Municipal bonds | |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |
Total recurring fair value measurements | 0 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | Asset backed securities | |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |
Total recurring fair value measurements | 0 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |
Total recurring fair value measurements | 31,489 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Money market funds | |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |
Total recurring fair value measurements | 0 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Certificates of deposit | |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |
Total recurring fair value measurements | 300 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Commercial paper | |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |
Total recurring fair value measurements | 21,075 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | U.S. treasury and agency securities | |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |
Total recurring fair value measurements | 3,500 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Corporate bonds and medium-term notes | |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |
Total recurring fair value measurements | 6,191 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Municipal bonds | |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |
Total recurring fair value measurements | 219 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Asset backed securities | |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |
Total recurring fair value measurements | $ 204 |
Cash, Cash Equivalents and In_7
Cash, Cash Equivalents and Investments - Additional Information (Detail) | Mar. 30, 2024 USD ($) investments | Dec. 30, 2023 USD ($) |
Derivative Instrument Detail [Abstract] | ||
Allowance for credit losses | $ | $ 0 | $ 0 |
Debt securities available-for-sale term | 2 years | |
Debt securities available-for-sale unrealized loss position number of positions | investments | 77 |
Derivative Instruments - Additi
Derivative Instruments - Additional Information (Detail) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 30, 2024 | Dec. 30, 2023 | |
Derivative Instrument Detail [Abstract] | ||
Maturity of foreign currency derivative | 30 days | |
Derivatives | $ 0 | $ 0 |
Equity - Schedule of Changes in
Equity - Schedule of Changes in Stockholders' Equity (Detail) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 30, 2024 | Apr. 01, 2023 | |
Class of Stock [Line Items] | ||
Beginning balance | $ 115,517 | $ 123,452 |
Common stock issued under employee plans | 462 | 801 |
Shares withheld for net share settlement of RSUs | (144) | (1,274) |
Equity-based compensation expense | 761 | 1,581 |
Net loss | (1,606) | (3,891) |
Other comprehensive loss | (67) | 179 |
Ending balance | 114,923 | 120,848 |
Common Stock and Additional Paid-in Capital | ||
Class of Stock [Line Items] | ||
Beginning balance | 210,346 | 206,381 |
Common stock issued under employee plans | 462 | 801 |
Shares withheld for net share settlement of RSUs | (144) | (1,274) |
Equity-based compensation expense | 761 | 1,581 |
Ending balance | 211,425 | 207,489 |
Treasury Stock | ||
Class of Stock [Line Items] | ||
Beginning balance | (29,551) | (29,551) |
Ending balance | (29,551) | (29,551) |
Accumulated Other Comprehensive Income | ||
Class of Stock [Line Items] | ||
Beginning balance | 97 | (193) |
Other comprehensive loss | (67) | 179 |
Ending balance | 30 | (14) |
Accumulated Deficit | ||
Class of Stock [Line Items] | ||
Beginning balance | (65,375) | (53,185) |
Net loss | (1,606) | (3,891) |
Ending balance | $ (66,981) | $ (57,076) |
Equity - Changes in Accumulated
Equity - Changes in Accumulated Other Comprehensive Income by Component (Detail) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 30, 2024 | Apr. 01, 2023 | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Beginning balance | $ 115,517 | $ 123,452 |
Other comprehensive income (loss), net of tax | (67) | 179 |
Ending balance | 114,923 | 120,848 |
Foreign currency | ||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Beginning balance | 159 | 291 |
Other comprehensive income (loss) before reclassification | (96) | 10 |
Amounts reclassified from other comprehensive income (loss) | 0 | 0 |
Other comprehensive income (loss), net of tax | (96) | 10 |
Ending balance | 63 | 301 |
Unrealized holding losses on available-for-sale investments | ||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Beginning balance | (62) | (484) |
Other comprehensive income (loss) before reclassification | 29 | 169 |
Amounts reclassified from other comprehensive income (loss) | 0 | 0 |
Other comprehensive income (loss), net of tax | 29 | 169 |
Ending balance | (33) | (315) |
Accumulated Other Comprehensive Income | ||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Beginning balance | 97 | (193) |
Other comprehensive income (loss) before reclassification | (67) | 179 |
Amounts reclassified from other comprehensive income (loss) | 0 | 0 |
Other comprehensive income (loss), net of tax | (67) | 179 |
Ending balance | $ 30 | $ (14) |
Equity - Additional Information
Equity - Additional Information (Detail) - USD ($) $ in Millions | Aug. 15, 2018 | Mar. 30, 2024 | Nov. 21, 2013 |
Equity [Abstract] | |||
Stock repurchase authorized amount | $ 40 | $ 30 | |
Increase in stock repurchase program | $ 10 | ||
Stock repurchase remained available for future stock repurchase | $ 10.4 |
Net Loss Per Share - Computatio
Net Loss Per Share - Computation of Basic and Diluted Net Income Per Share (Detail) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | |
Mar. 30, 2024 | Apr. 01, 2023 | |
Earnings Per Share [Abstract] | ||
Net loss from continuing operations | $ (2,701) | $ (4,168) |
Net income from discontinued operations, net of tax | 1,095 | 277 |
Net loss | $ (1,606) | $ (3,891) |
Weighted-average shares – basic | 26,522 | 25,781 |
Effect of dilutive potential common shares | 0 | 0 |
Weighted-average shares – diluted | 26,522 | 25,781 |
Basic And Diluted Earnings Per Share [Abstract] | ||
Basic – continuing operations | $ (0.1) | $ (0.16) |
Diluted – continuing operations | (0.1) | (0.16) |
Basic – discontinued operations | 0.04 | 0.01 |
Diluted – discontinued operations | 0.04 | 0.01 |
Basic – net loss | (0.06) | (0.15) |
Diluted – net loss | $ (0.06) | $ (0.15) |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Detail) - USD ($) | 3 Months Ended | |
Mar. 30, 2024 | Apr. 01, 2023 | |
Income Taxes [Line Items] | ||
Provision for income taxes | $ 476,000 | $ 386,000 |
Income tax charge (benefit) | 135,000 | 162,000 |
Income tax provision on earnings of subsidiaries | 344,000 | $ 224,000 |
Trade and Other Accounts Receivable Current | Employee Retention Credit | ||
Income Taxes [Line Items] | ||
Government assistance receivable current | 2,400,000 | |
Discontinued Operations | Employee Retention Credit | ||
Income Taxes [Line Items] | ||
Government assistance recognized | 933,000 | |
Other Nonoperating Income (Expense) | Employee Retention Credit | ||
Income Taxes [Line Items] | ||
Government assistance recognized | $ 1,500,000 |
Restructuring and Other Costs_2
Restructuring and Other Costs, Net - Additional Information (Detail) | 3 Months Ended | |
Jan. 10, 2022 USD ($) Installment | Apr. 02, 2022 USD ($) | |
Restructuring Cost and Reserve [Line Items] | ||
Other Employee benefits expense | $ 665,000 | |
Operating lease, first instalment payments | $ 308,000 | |
Operating lease, quarterly instalment payments | $ 259,000 | |
Number of operating lease payments | Installment | 7 | |
Operating cash outflows from operating leases | $ 2,100,000 |
Restructuring and Other Costs_3
Restructuring and Other Costs, Net - Changes in Restructuring Reserves (Detail) - Other Restructuring $ in Thousands | 3 Months Ended |
Apr. 01, 2023 USD ($) | |
Restructuring Cost and Reserve [Line Items] | |
Beginning balance | $ 318 |
Provision for restructuring charges associated with Photonics divestiture | 3 |
Cash payments made | (81) |
Ending balance | $ 240 |
Acquisition of Hia, Inc.- Addit
Acquisition of Hia, Inc.- Additional Information (Detail) - USD ($) | 3 Months Ended | |||
Jan. 17, 2023 | Aug. 26, 2022 | Mar. 30, 2024 | Apr. 01, 2023 | |
Business Combinations [Line Items] | ||||
Intangible assets amortized on a straight line basis over a period | 8 years 3 months 18 days | |||
Amortization of intangible assets | $ 34,000 | $ 34,000 | ||
Contingent consideration amount | $ 250,000 | |||
Hia Inc | ||||
Business Combinations [Line Items] | ||||
Estimated contingent consideration amounts | $ 500,000 | |||
Royalty amount obligated to pay for each magnetic bar sold | 1,500 | |||
Royalty payment become due and payable immediately if there is effects a change of control or sale,transfer or disposition to other third party net of previously paid amounts | 1,700,000 | |||
Transaction costs | 63,000 | |||
Stock Purchase Agreement | Hia Inc | ||||
Business Combinations [Line Items] | ||||
Aggregate purchase price | $ 700,000 | |||
Intangible Assets Amortization Period Remainder of Fiscal Year | Hia Inc | Technology-Based Intangible Assets | ||||
Business Combinations [Line Items] | ||||
Amortization of intangible assets | 102,000 | |||
Intangible Assets Amortization Period Fiscal Year 2025 to Fiscal Year 2030 | Hia Inc | Technology-Based Intangible Assets | ||||
Business Combinations [Line Items] | ||||
Amortization of intangible assets | $ 136,000 |
Acquisition of Hia, Inc.- Sched
Acquisition of Hia, Inc.- Schedule of Tabular Form of Finite Lived Technology Intangible Assets Tabular Form of Finite Lived Technology Intangible Assets (Detail) - USD ($) $ in Thousands | Mar. 30, 2024 | Dec. 30, 2023 |
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Gross carrying amount | $ 1,132 | $ 1,132 |
Accumulated Amortization | (212) | (178) |
Net carrying amount | $ 920 | $ 954 |